Supernus Pharmaceuticals | SUPN - Capitaux D'Emprunt





Capitaux D'Emprunt Changement Date
Abbott USD 29.64B 19.74B 2026-03
ANI Pharmaceuticals USD 286M 5.84M 2026-03
Aurora Cannabis CAD 33.2M 1.79M 2025-12
Bristol-Myers Squibb USD 42.15B 698M 2026-03
Canopy Growth CAD 224.99M 1.34M 2025-12
Cara Therapeutics USD 0 0 2025-03
Eisai JPY 134.78B 12M 2026-03
Eli Lilly USD 39.37B 1.5B 2026-03
Novo Nordisk DKK 119.17B 231M 2026-03
Pacira USD 367.66M 4.53M 2026-03
Perrigo USD 3.62B 17.5M 2026-03
Pfizer USD 60.57B 1.08B 2026-03
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
United Therapeutics USD 100M 100M 2024-06
Xeris Pharmaceuticals USD 221.22M 889K 2026-03